Is DICE or NOBL a better dividend investment in 2026?

DICE currently yields 4.21% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: DICE offers higher current income.

What is the dividend yield difference between DICE and NOBL?

DICE has a forward dividend yield of 4.21% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 0.21 percentage points.

Home › Compare › DICE vs NOBL

DICE vs NOBL: Dividend Comparison 2026

DICE yields 4.21% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NOBL wins by $1.7K in total portfolio value· pulled ahead in Year 2

INVESTMENT

TIME HORIZON10 years

DICE

● Live price

4.21%

Share price

$47.55

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.3K

Annual income

$550.89

Full DICE calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — DICE vs NOBL

📍 NOBL pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DICE	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DICE + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DICE pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DICE

Annual income on $10K today (after 15% tax)

$357.52/yr

After 10yr DRIP, annual income (after tax)

$468.26/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, NOBL beats the other by $296.06/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DICE + NOBL for your $10,000?

DICE: 50%NOBL: 50%

100% NOBL50/50100% DICE

Portfolio after 10yr

$27.2K

Annual income

$725.04/yr

Blended yield

2.67%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on DICE right now

DICE

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$60.00

+26.2% upside vs current

Range: $60.00 — $60.00

Altman Z

42.9

Piotroski

3/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DICE buys

NOBL buys

No recent congressional trades found for DICE or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDICENOBL

Forward yield	4.21% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$26.3K	$28.0K ✓
Annual income after 10y	$550.89	$899.19 ✓
Total dividends collected	$4.9K	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: DICE vs NOBL ($10,000, DRIP)

Year	DICE Portfolio	DICE Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1	$11,121	$420.61	$11,120	$420.00	+$1.00 → DICE
2← crossover	$12,336	$437.14	$12,357	$458.31	$21.00 → NOBL
3	$13,653	$453.20	$13,721	$499.76	$68.00 → NOBL
4	$15,077	$468.76	$15,227	$544.58	$150.00 → NOBL
5	$16,617	$483.81	$16,885	$593.02	$268.00 → NOBL
6	$18,278	$498.31	$18,713	$645.34	$435.00 → NOBL
7	$20,070	$512.28	$20,724	$701.81	$654.00 → NOBL
8	$22,000	$525.70	$22,938	$762.73	$938.00 → NOBL
9	$24,079	$538.57	$25,372	$828.41	$1.3K → NOBL
10	$26,315	$550.89	$28,047	$899.19	$1.7K → NOBL

DICE vs NOBL: Complete Analysis 2026

DICE — Stock

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Full DICE Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this DICE vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DICE vs SCHD DICE vs JEPI DICE vs O DICE vs KO DICE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.